CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing ...

Pfizer’s chief executive said he was “disappointed” with Robert F Kennedy Jr’s refusal to disavow the debunked link between vaccines and autism, even as he expressed confidence that the Trump ...

Pfizer CEO Albert Bourla unpacks the impact of the nomination on 'The Claman Countdown.' ...

A Semafor analysis of government schedules showed little access for business executives, a freeze-out expected to reverse ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Badu Gili: Healing Spirit is on display from sunset at the Sydney Opera House until December 2025. This story is from the ...

There was a sense of guarded optimism in the air at the latest World Economic Forum. But CEOs want their CCOs to step up and ...

Still, Trump looks to be using tariff announcements "primarily as a negotiating tool" and this could help the euro to recover ...

FDA Commissioner Robert Califf is closing the book on his second stint leading the agency that regulates products accounting for about 20 cents of every dollar that Americans spend.

Big Pharma is downplaying — for now — the potential negative impacts of President Donald Trump’s China tariffs on their ...

Despite last week’s Arctic blast, a buoyancy filled the air as if spring had arrived after a four-year freeze. U.S.

President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...